potassium;6-bromo-2-chloroquinoline;4-[2-[4-(6-bromoquinolin-2-yl)phenoxy]ethyl]-1,3,3-trimethylpiperazin-2-one;6-methyl-1-(4-methylphenyl)sulfonyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[2,3-c]pyridin-7-one;6-methyl-1-(4-methylphenyl)sulfonyl-4-[2-[4-[2-(2,2,4-trimethyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-6-yl]pyrrolo[2,3-c]pyridin-7-one;6-methyl-4-[2-[4-[2-(2,2,4-trimethyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-6-yl]-1H-pyrrolo[2,3-c]pyridin-7-one;1,3,3-trimethyl-4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]piperazin-2-one;hydroxide

C146H162B2Br2ClKN18O20S2 — CID 163427923

IUPACpotassium;6-bromo-2-chloroquinoline;4-[2-[4-(6-bromoquinolin-2-yl)phenoxy]ethyl]-1,3,3-trimethylpiperazin-2-one;6-methyl-1-(4-methylphenyl)sulfonyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[2,3-c]pyridin-7-one;6-methyl-1-(4-methylphenyl)sulfonyl-4-[2-[4-[2-(2,2,4-trimethyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-6-yl]pyrrolo[2,3-c]pyridin-7-one;6-methyl-4-[2-[4-[2-(2,2,4-trimethyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-6-yl]-1H-pyrrolo[2,3-c]pyridin-7-one;1,3,3-trimethyl-4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]piperazin-2-one;hydroxide
SMILESCN1CCN(CCOc2ccc(-c3ccc4cc(-c5cn(C)c(=O)c6[nH]ccc56)ccc4n3)cc2)C(C)(C)C1=O.CN1CCN(CCOc2ccc(-c3ccc4cc(Br)ccc4n3)cc2)C(C)(C)C1=O.CN1CCN(CCOc2ccc(B3OC(C)(C)C(C)(C)O3)cc2)C(C)(C)C1=O.Cc1ccc(S(=O)(=O)n2ccc3c(-c4ccc5nc(-c6ccc(OCCN7CCN(C)C(=O)C7(C)C)cc6)ccc5c4)cn(C)c(=O)c32)cc1.Cc1ccc(S(=O)(=O)n2ccc3c(B4OC(C)(C)C(C)(C)O4)cn(C)c(=O)c32)cc1.Clc1ccc2cc(Br)ccc2n1.[K+].[OH-]
InChIInChI=1S/C39H39N5O5S.C32H33N5O3.C24H26BrN3O2.C21H25BN2O5S.C21H33BN2O4.C9H5BrClN.K.H2O/c1-26-6-14-31(15-7-26)50(47,48)44-19-18-32-33(25-42(5)37(45)36(32)44)28-10-16-35-29(24-28)11-17-34(40-35)27-8-12-30(13-9-27)49-23-22-43-21-20-41(4)38(46)39(43,2)3;1-32(2)31(39)35(3)15-16-37(32)17-18-40-24-9-5-21(6-10-24)27-12-8-23-19-22(7-11-28(23)34-27)26-20-36(4)30(38)29-25(26)13-14-33-29;1-24(2)23(29)27(3)12-13-28(24)14-15-30-20-8-4-17(5-9-20)21-10-6-18-16-19(25)7-11-22(18)26-21;1-14-7-9-15(10-8-14)30(26,27)24-12-11-16-17(13-23(6)19(25)18(16)24)22-28-20(2,3)21(4,5)29-22;1-19(2)18(25)23(7)12-13-24(19)14-15-26-17-10-8-16(9-11-17)22-27-20(3,4)21(5,6)28-22;10-7-2-3-8-6(5-7)1-4-9(11)12-8;;/h6-19,24-25H,20-23H2,1-5H3;5-14,19-20,33H,15-18H2,1-4H3;4-11,16H,12-15H2,1-3H3;7-13H,1-6H3;8-11H,12-15H2,1-7H3;1-5H;;1H2/q;;;;;;+1;/p-1
InChIKeyAOCNAPZSQNGREE-UHFFFAOYSA-M
MW2809.12 g/mol
LogP19.55
Rot. Bonds27

About potassium;6-bromo-2-chloroquinoline;4-[2-[4-(6-bromoquinolin-2-yl)phenoxy]ethyl]-1,3,3-trimethylpiperazin-2-one;6-methyl-1-(4-methylphenyl)sulfonyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[2,3-c]pyridin-7-one;6-methyl-1-(4-methylphenyl)sulfonyl-4-[2-[4-[2-(2,2,4-trimethyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-6-yl]pyrrolo[2,3-c]pyridin-7-one;6-methyl-4-[2-[4-[2-(2,2,4-trimethyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-6-yl]-1H-pyrrolo[2,3-c]pyridin-7-one;1,3,3-trimethyl-4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]piperazin-2-one;hydroxide

potassium;6-bromo-2-chloroquinoline;4-[2-[4-(6-bromoquinolin-2-yl)phenoxy]ethyl]-1,3,3-trimethylpiperazin-2-one;6-methyl-1-(4-methylphenyl)sulfonyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[2,3-c]pyridin-7-one;6-methyl-1-(4-methylphenyl)sulfonyl-4-[2-[4-[2-(2,2,4-trimethyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-6-yl]pyrrolo[2,3-c]pyridin-7-one;6-methyl-4-[2-[4-[2-(2,2,4-trimethyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-6-yl]-1H-pyrrolo[2,3-c]pyridin-7-one;1,3,3-trimethyl-4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]piperazin-2-one;hydroxide (PubChem CID 163427923) has the molecular formula C146H162B2Br2ClKN18O20S2 and a molecular weight of 2809.12 g/mol. Its IUPAC name is potassium;6-bromo-2-chloroquinoline;4-[2-[4-(6-bromoquinolin-2-yl)phenoxy]ethyl]-1,3,3-trimethylpiperazin-2-one;6-methyl-1-(4-methylphenyl)sulfonyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[2,3-c]pyridin-7-one;6-methyl-1-(4-methylphenyl)sulfonyl-4-[2-[4-[2-(2,2,4-trimethyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-6-yl]pyrrolo[2,3-c]pyridin-7-one;6-methyl-4-[2-[4-[2-(2,2,4-trimethyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-6-yl]-1H-pyrrolo[2,3-c]pyridin-7-one;1,3,3-trimethyl-4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]piperazin-2-one;hydroxide.

Molecular Properties

Compound Namepotassium;6-bromo-2-chloroquinoline;4-[2-[4-(6-bromoquinolin-2-yl)phenoxy]ethyl]-1,3,3-trimethylpiperazin-2-one;6-methyl-1-(4-methylphenyl)sulfonyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[2,3-c]pyridin-7-one;6-methyl-1-(4-methylphenyl)sulfonyl-4-[2-[4-[2-(2,2,4-trimethyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-6-yl]pyrrolo[2,3-c]pyridin-7-one;6-methyl-4-[2-[4-[2-(2,2,4-trimethyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-6-yl]-1H-pyrrolo[2,3-c]pyridin-7-one;1,3,3-trimethyl-4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]piperazin-2-one;hydroxide
PubChem CID163427923
Molecular FormulaC146H162B2Br2ClKN18O20S2
Molecular Weight2809.12 g/mol
Exact Mass2804.95
IUPAC Namepotassium;6-bromo-2-chloroquinoline;4-[2-[4-(6-bromoquinolin-2-yl)phenoxy]ethyl]-1,3,3-trimethylpiperazin-2-one;6-methyl-1-(4-methylphenyl)sulfonyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[2,3-c]pyridin-7-one;6-methyl-1-(4-methylphenyl)sulfonyl-4-[2-[4-[2-(2,2,4-trimethyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-6-yl]pyrrolo[2,3-c]pyridin-7-one;6-methyl-4-[2-[4-[2-(2,2,4-trimethyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-6-yl]-1H-pyrrolo[2,3-c]pyridin-7-one;1,3,3-trimethyl-4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]piperazin-2-one;hydroxide
SMILESCN1CCN(CCOc2ccc(-c3ccc4cc(-c5cn(C)c(=O)c6[nH]ccc56)ccc4n3)cc2)C(C)(C)C1=O.CN1CCN(CCOc2ccc(-c3ccc4cc(Br)ccc4n3)cc2)C(C)(C)C1=O.CN1CCN(CCOc2ccc(B3OC(C)(C)C(C)(C)O3)cc2)C(C)(C)C1=O.Cc1ccc(S(=O)(=O)n2ccc3c(-c4ccc5nc(-c6ccc(OCCN7CCN(C)C(=O)C7(C)C)cc6)ccc5c4)cn(C)c(=O)c32)cc1.Cc1ccc(S(=O)(=O)n2ccc3c(B4OC(C)(C)C(C)(C)O4)cn(C)c(=O)c32)cc1.Clc1ccc2cc(Br)ccc2n1.[K+].[OH-]
InChIInChI=1S/C39H39N5O5S.C32H33N5O3.C24H26BrN3O2.C21H25BN2O5S.C21H33BN2O4.C9H5BrClN.K.H2O/c1-26-6-14-31(15-7-26)50(47,48)44-19-18-32-33(25-42(5)37(45)36(32)44)28-10-16-35-29(24-28)11-17-34(40-35)27-8-12-30(13-9-27)49-23-22-43-21-20-41(4)38(46)39(43,2)3;1-32(2)31(39)35(3)15-16-37(32)17-18-40-24-9-5-21(6-10-24)27-12-8-23-19-22(7-11-28(23)34-27)26-20-36(4)30(38)29-25(26)13-14-33-29;1-24(2)23(29)27(3)12-13-28(24)14-15-30-20-8-4-17(5-9-20)21-10-6-18-16-19(25)7-11-22(18)26-21;1-14-7-9-15(10-8-14)30(26,27)24-12-11-16-17(13-23(6)19(25)18(16)24)22-28-20(2,3)21(4,5)29-22;1-19(2)18(25)23(7)12-13-24(19)14-15-26-17-10-8-16(9-11-17)22-27-20(3,4)21(5,6)28-22;10-7-2-3-8-6(5-7)1-4-9(11)12-8;;/h6-19,24-25H,20-23H2,1-5H3;5-14,19-20,33H,15-18H2,1-4H3;4-11,16H,12-15H2,1-3H3;7-13H,1-6H3;8-11H,12-15H2,1-7H3;1-5H;;1H2/q;;;;;;+1;/p-1
InChIKeyAOCNAPZSQNGREE-UHFFFAOYSA-M
XLogP19.55
TPSA409.53 Ų
H-Bond Donors1
H-Bond Acceptors33
Rotatable Bonds27
Heavy Atoms192
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002809.12
LogP ≤ 519.55
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1033

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze potassium;6-bromo-2-chloroquinoline;4-[2-[4-(6-bromoquinolin-2-yl)phenoxy]ethyl]-1,3,3-trimethylpiperazin-2-one;6-methyl-1-(4-methylphenyl)sulfonyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[2,3-c]pyridin-7-one;6-methyl-1-(4-methylphenyl)sulfonyl-4-[2-[4-[2-(2,2,4-trimethyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-6-yl]pyrrolo[2,3-c]pyridin-7-one;6-methyl-4-[2-[4-[2-(2,2,4-trimethyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-6-yl]-1H-pyrrolo[2,3-c]pyridin-7-one;1,3,3-trimethyl-4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]piperazin-2-one;hydroxide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of potassium;6-bromo-2-chloroquinoline;4-[2-[4-(6-bromoquinolin-2-yl)phenoxy]ethyl]-1,3,3-trimethylpiperazin-2-one;6-methyl-1-(4-methylphenyl)sulfonyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[2,3-c]pyridin-7-one;6-methyl-1-(4-methylphenyl)sulfonyl-4-[2-[4-[2-(2,2,4-trimethyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-6-yl]pyrrolo[2,3-c]pyridin-7-one;6-methyl-4-[2-[4-[2-(2,2,4-trimethyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-6-yl]-1H-pyrrolo[2,3-c]pyridin-7-one;1,3,3-trimethyl-4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]piperazin-2-one;hydroxide?
The IUPAC name of potassium;6-bromo-2-chloroquinoline;4-[2-[4-(6-bromoquinolin-2-yl)phenoxy]ethyl]-1,3,3-trimethylpiperazin-2-one;6-methyl-1-(4-methylphenyl)sulfonyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[2,3-c]pyridin-7-one;6-methyl-1-(4-methylphenyl)sulfonyl-4-[2-[4-[2-(2,2,4-trimethyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-6-yl]pyrrolo[2,3-c]pyridin-7-one;6-methyl-4-[2-[4-[2-(2,2,4-trimethyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-6-yl]-1H-pyrrolo[2,3-c]pyridin-7-one;1,3,3-trimethyl-4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]piperazin-2-one;hydroxide (CID 163427923) is potassium;6-bromo-2-chloroquinoline;4-[2-[4-(6-bromoquinolin-2-yl)phenoxy]ethyl]-1,3,3-trimethylpiperazin-2-one;6-methyl-1-(4-methylphenyl)sulfonyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[2,3-c]pyridin-7-one;6-methyl-1-(4-methylphenyl)sulfonyl-4-[2-[4-[2-(2,2,4-trimethyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-6-yl]pyrrolo[2,3-c]pyridin-7-one;6-methyl-4-[2-[4-[2-(2,2,4-trimethyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-6-yl]-1H-pyrrolo[2,3-c]pyridin-7-one;1,3,3-trimethyl-4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]piperazin-2-one;hydroxide.
What is the SMILES notation for potassium;6-bromo-2-chloroquinoline;4-[2-[4-(6-bromoquinolin-2-yl)phenoxy]ethyl]-1,3,3-trimethylpiperazin-2-one;6-methyl-1-(4-methylphenyl)sulfonyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[2,3-c]pyridin-7-one;6-methyl-1-(4-methylphenyl)sulfonyl-4-[2-[4-[2-(2,2,4-trimethyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-6-yl]pyrrolo[2,3-c]pyridin-7-one;6-methyl-4-[2-[4-[2-(2,2,4-trimethyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-6-yl]-1H-pyrrolo[2,3-c]pyridin-7-one;1,3,3-trimethyl-4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]piperazin-2-one;hydroxide?
The canonical SMILES for potassium;6-bromo-2-chloroquinoline;4-[2-[4-(6-bromoquinolin-2-yl)phenoxy]ethyl]-1,3,3-trimethylpiperazin-2-one;6-methyl-1-(4-methylphenyl)sulfonyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[2,3-c]pyridin-7-one;6-methyl-1-(4-methylphenyl)sulfonyl-4-[2-[4-[2-(2,2,4-trimethyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-6-yl]pyrrolo[2,3-c]pyridin-7-one;6-methyl-4-[2-[4-[2-(2,2,4-trimethyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-6-yl]-1H-pyrrolo[2,3-c]pyridin-7-one;1,3,3-trimethyl-4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]piperazin-2-one;hydroxide is CN1CCN(CCOc2ccc(-c3ccc4cc(-c5cn(C)c(=O)c6[nH]ccc56)ccc4n3)cc2)C(C)(C)C1=O.CN1CCN(CCOc2ccc(-c3ccc4cc(Br)ccc4n3)cc2)C(C)(C)C1=O.CN1CCN(CCOc2ccc(B3OC(C)(C)C(C)(C)O3)cc2)C(C)(C)C1=O.Cc1ccc(S(=O)(=O)n2ccc3c(-c4ccc5nc(-c6ccc(OCCN7CCN(C)C(=O)C7(C)C)cc6)ccc5c4)cn(C)c(=O)c32)cc1.Cc1ccc(S(=O)(=O)n2ccc3c(B4OC(C)(C)C(C)(C)O4)cn(C)c(=O)c32)cc1.Clc1ccc2cc(Br)ccc2n1.[K+].[OH-].
What is the InChIKey of potassium;6-bromo-2-chloroquinoline;4-[2-[4-(6-bromoquinolin-2-yl)phenoxy]ethyl]-1,3,3-trimethylpiperazin-2-one;6-methyl-1-(4-methylphenyl)sulfonyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[2,3-c]pyridin-7-one;6-methyl-1-(4-methylphenyl)sulfonyl-4-[2-[4-[2-(2,2,4-trimethyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-6-yl]pyrrolo[2,3-c]pyridin-7-one;6-methyl-4-[2-[4-[2-(2,2,4-trimethyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-6-yl]-1H-pyrrolo[2,3-c]pyridin-7-one;1,3,3-trimethyl-4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]piperazin-2-one;hydroxide?
The InChIKey is AOCNAPZSQNGREE-UHFFFAOYSA-M. The full InChI is InChI=1S/C39H39N5O5S.C32H33N5O3.C24H26BrN3O2.C21H25BN2O5S.C21H33BN2O4.C9H5BrClN.K.H2O/c1-26-6-14-31(15-7-26)50(47,48)44-19-18-32-33(25-42(5)37(45)36(32)44)28-10-16-35-29(24-28)11-17-34(40-35)27-8-12-30(13-9-27)49-23-22-43-21-20-41(4)38(46)39(43,2)3;1-32(2)31(39)35(3)15-16-37(32)17-18-40-24-9-5-21(6-10-24)27-12-8-23-19-22(7-11-28(23)34-27)26-20-36(4)30(38)29-25(26)13-14-33-29;1-24(2)23(29)27(3)12-13-28(24)14-15-30-20-8-4-17(5-9-20)21-10-6-18-16-19(25)7-11-22(18)26-21;1-14-7-9-15(10-8-14)30(26,27)24-12-11-16-17(13-23(6)19(25)18(16)24)22-28-20(2,3)21(4,5)29-22;1-19(2)18(25)23(7)12-13-24(19)14-15-26-17-10-8-16(9-11-17)22-27-20(3,4)21(5,6)28-22;10-7-2-3-8-6(5-7)1-4-9(11)12-8;;/h6-19,24-25H,20-23H2,1-5H3;5-14,19-20,33H,15-18H2,1-4H3;4-11,16H,12-15H2,1-3H3;7-13H,1-6H3;8-11H,12-15H2,1-7H3;1-5H;;1H2/q;;;;;;+1;/p-1.
What are the key properties of potassium;6-bromo-2-chloroquinoline;4-[2-[4-(6-bromoquinolin-2-yl)phenoxy]ethyl]-1,3,3-trimethylpiperazin-2-one;6-methyl-1-(4-methylphenyl)sulfonyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[2,3-c]pyridin-7-one;6-methyl-1-(4-methylphenyl)sulfonyl-4-[2-[4-[2-(2,2,4-trimethyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-6-yl]pyrrolo[2,3-c]pyridin-7-one;6-methyl-4-[2-[4-[2-(2,2,4-trimethyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-6-yl]-1H-pyrrolo[2,3-c]pyridin-7-one;1,3,3-trimethyl-4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]piperazin-2-one;hydroxide?
potassium;6-bromo-2-chloroquinoline;4-[2-[4-(6-bromoquinolin-2-yl)phenoxy]ethyl]-1,3,3-trimethylpiperazin-2-one;6-methyl-1-(4-methylphenyl)sulfonyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[2,3-c]pyridin-7-one;6-methyl-1-(4-methylphenyl)sulfonyl-4-[2-[4-[2-(2,2,4-trimethyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-6-yl]pyrrolo[2,3-c]pyridin-7-one;6-methyl-4-[2-[4-[2-(2,2,4-trimethyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-6-yl]-1H-pyrrolo[2,3-c]pyridin-7-one;1,3,3-trimethyl-4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]piperazin-2-one;hydroxide has a molecular weight of 2809.12 g/mol, XLogP of 19.55, 27 rotatable bonds, 1 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for potassium;6-bromo-2-chloroquinoline;4-[2-[4-(6-bromoquinolin-2-yl)phenoxy]ethyl]-1,3,3-trimethylpiperazin-2-one;6-methyl-1-(4-methylphenyl)sulfonyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[2,3-c]pyridin-7-one;6-methyl-1-(4-methylphenyl)sulfonyl-4-[2-[4-[2-(2,2,4-trimethyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-6-yl]pyrrolo[2,3-c]pyridin-7-one;6-methyl-4-[2-[4-[2-(2,2,4-trimethyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-6-yl]-1H-pyrrolo[2,3-c]pyridin-7-one;1,3,3-trimethyl-4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]piperazin-2-one;hydroxide is sourced from PubChem (CID 163427923), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).